Sherene Loi Joint 2016 COSA and ANZBCTG Annual Scientific Meeting

Sherene Loi

Professor Loi is a Medical Oncologist specialized in breast cancer treatment as well as a clinician scientist (group leader) with expertise in genomics, immunology and drug development at the Peter MacCallum Cancer Centre, Melbourne, Australia. She is recognised internationally as a leading clinician scientist whose work has led to new insights into the breast cancer immunology field as well as leading international clinical trials in breast cancer immunotherapy. To date, she has published over 300 peer-reviewed research articles with a lifetime H-index of >100. Her recent work has been highly influential: she is ranked in the top 1% of highly cited researchers globally by the Web of Science. She Co-Chairs the International Breast Cancer Study Group (IBCSG) based in Bern, Switzerland, one of the largest global academic breast cancer trial cooperative groups. She is a current holder of the Inaugural National Breast Cancer Foundation (NBCF) of Australia Endowed Chair and in 2021 received one the Prime Ministers’ Awards for Science.

Abstracts this author is presenting: